PRDX1 negatively regulates bleomycin-induced pulmonary fibrosis via inhibiting the epithelial-mesenchymal transition and lung fibroblast proliferation in vitro and in vivo
Open Access
- 2 June 2023
- journal article
- research article
- Published by Springer Nature in Cellular & Molecular Biology Letters
- Vol. 28 (1) , 1-19
Abstract
Background: Pulmonary fibrosis is a major category of end-stage changes in lung diseases, characterized by lung epithelial cell damage, proliferation of fibroblasts, and accumulation of extracellular matrix. Peroxiredoxin 1 (PRDX1), a member of the peroxiredoxin protein family, participates in the regulation of the levels of reactive oxygen species in cells and various other physiological activities, as well as the occurrence and development of diseases by functioning as a chaperonin. Methods: Experimental methods including MTT assay, morphological observation of fibrosis, wound healing assay, fluorescence microscopy, flow cytometry, ELISA, western blot, transcriptome sequencing, and histopathological analysis were used in this study. Results: PRDX1 knockdown increased ROS levels in lung epithelial cells and promoted epithelial-mesenchymal transition (EMT) through the PI3K/Akt and JNK/Smad signalling pathways. PRDX1 knockout significantly increased TGF-β secretion, ROS production, and cell migration in primary lung fibroblasts. PRDX1 deficiency also increased cell proliferation, cell cycle circulation, and fibrosis progression through the PI3K/Akt and JNK/Smad signalling pathways. BLM treatment induced more severe pulmonary fibrosis in PRDX1-knockout mice, mainly through the PI3K/Akt and JNK/Smad signalling pathways. Conclusions: Our findings strongly suggest that PRDX1 is a key molecule in BLM-induced lung fibrosis progression and acts through modulating EMT and lung fibroblast proliferation; therefore, it may be a therapeutic target for the treatment of BLM-induced lung fibrosis.Keywords
This publication has 70 references indexed in Scilit:
- Human peroxiredoxin 1 modulates TGF-β1-induced epithelial–mesenchymal transition through its peroxidase activityBiochemical and Biophysical Research Communications, 2012
- Inhibition of PI3K Prevents the Proliferation and Differentiation of Human Lung Fibroblasts into Myofibroblasts: The Role of Class I P110 IsoformsPLOS ONE, 2011
- ER Stress and Its Functional Link to Mitochondria: Role in Cell Survival and DeathCold Spring Harbor Perspectives in Biology, 2011
- c-Jun N-Terminal Kinase 1 Promotes Transforming Growth Factor–β1–Induced Epithelial-to-Mesenchymal Transition via Control of Linker Phosphorylation and Transcriptional Activity of Smad3American Journal of Respiratory Cell and Molecular Biology, 2011
- Phosphatidylinositol-3-Kinase/Akt Regulates Bleomycin-Induced Fibroblast Proliferation and Collagen ProductionAmerican Journal of Respiratory Cell and Molecular Biology, 2010
- Peroxiredoxin 1 and its role in cell signalingCell Cycle, 2009
- Jun N-terminal kinase 1 regulates epithelial-to-mesenchymal transition induced by TGF-β1Journal of Cell Science, 2008
- Cellular and molecular mechanisms of fibrosisThe Journal of Pathology, 2007
- Bleomycin induces alveolar epithelial cell death through JNK-dependent activation of the mitochondrial death pathwayAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2005
- Requirement of TGF‐β receptor‐dependent activation of c‐Jun N‐terminal kinases (JNKs)/stress‐activated protein kinases (Sapks) for TGF‐β up‐regulation of the urokinase‐type plasminogen activator receptorJournal of Cellular Physiology, 2003